We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A study found that pairing a tuberculosis (TB) drug with highly active antiretroviral (ARV) therapy is more effective than either therapy on its own at preventing full-blown TB in people with HIV.
Updated treatment guidelines issued by the International AIDS Society-USA include three GlaxoSmithKline (GSK) medications as part of the society's recommendations for initial antiretroviral therapy.
The UK's National Institute for Health and Clinical Excellence (NICE) has published a positive final appraisal document on the class of breast cancer drugs known as aromatase inhibitors (AIs) for post-surgery use.
Ranbaxy Laboratories has received approval in India to manufacture and market Triviro-LNS and Triviro-LNS DS, both triple antiretroviral (ARV) combinations, for children.
Therapeutics, Inc. announced it has entered into agreements to raise approximately $16.8 million through the sale of 2,918,255 shares of common stock to Olympus Corporation as well as new and existing institutional investors at $5.75 per share.
Epeius Biotechnologies announced the Bureau of Food and Drugs (BFAD), the Philippine drug regulatory body, has granted Epeius Biotechnologies accelerated approval for the company's lead clinical product, Rexin-G for the treatment of all solid tumors.
Ethypharm India, subsidiary of leading French multinational drug delivery company Ethypharm S.A., has announced out-licensing of five new products in different therapeutic segments with Globalpharma Co LLC. Globalpharma is a leading joint venture company in UAE, a subsidiary of Dubai Investment PJC.
Euroscreen s.a. announced that it filed a complaint in the Osaka District Court (case number H18 (wa) 7760) alleging that Ono Pharmaceuticals Co., Ltd. infringed a basic CCR5 patent (JP Patent No. 3288384) in the discovery of Ono's CCR5 drug candidates.
Ranbaxy Laboratories Ltd on Thursday said it will sell off its manufacturing unit in Ireland as it consolidates production activity for Europe and the CIS countries, at the plant of recently acquired Terapia in Romania.